Here is a list of top stocks that are likely to be in focus in today's trading session

As per the USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspectional findings.

Orchid Pharma today said it has received establishment inspection report (EIR) from the US health regulator for its Alathur facility in Tam...

The stock rose 19.99% to hit a high of Rs 21.35, its highest level since August 23.

USFDA releases a copy of the EIR to the establishment that was the subject of an FDA or FDA-contracted inspection when the agency determine...

USFDA releases a copy of the EIR to the establishment that was the subject of an FDA or FDA-contracted inspection when the agency determine...

Most experts said regulatory hurdles are going to be the biggest overhang for the sector and, hence, investors should remain selective.

Chennai-based Orchid Pharma has received final approval from the US health regulator for its generic version of rasagiline tablets.

Orchid Pharma has received Establishment Inspection Report (EIR) from the US health regulator on the successful inspection closure for its ...

The US is the largest market for domestic generic companies, contributing 25-55% of revenues for large companies, while India supplies arou...

Orchid Chemicals Ltd rallied as much as 8.07 per cent in trade on Friday, after the pharma major received approval from the USFDA.

Orchid Chemicals and Pharmaceuticals Ltd has said its Cephalosporin API manufacturing (antibiotic) complex in Alathur, Chennai, has success...

Orchid Chemicals & Pharmaceuticals, a leading generic drug manufacturer, on Thursday said it will buy US-based marketing company Karalex Ph...

Pharma firm Orchid Chemicals & Pharmaceuticals today said it has received the US drug regulator's nod for its Piperacillin and Tazobactam i...

'Eventful' would perhaps be the most apt term to describe the year 2008 for the Indian pharmaceutical industry.

'Eventful' would perhaps be the most apt term to describe the year 2008 for the Indian pharmaceutical industry. It saw hefty excise duty cu...

Three generic pharmaceutical companies, including one from India, have taken legal action against US pharma major Wyeth.